These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31779636)

  • 1. A few ethical issues in translational research for gene and cell therapy.
    Riva L; Petrini C
    J Transl Med; 2019 Nov; 17(1):395. PubMed ID: 31779636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
    Lucas-Samuel S; Ferry N; Trouvin JH
    Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Oversight of Cell and Gene Therapy Products in Canada.
    Ridgway A; Agbanyo F; Wang J; Rosu-Myles M
    Adv Exp Med Biol; 2015; 871():49-71. PubMed ID: 26374212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory Frameworks for Gene and Cell Therapies in Japan.
    Maeda D; Yamaguchi T; Ishizuka T; Hirata M; Takekita K; Sato D
    Adv Exp Med Biol; 2015; 871():147-62. PubMed ID: 26374217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland.
    Marti A
    Adv Exp Med Biol; 2015; 871():131-45. PubMed ID: 26374216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Singapore.
    Goh CW; Kellathur SN; Ong LL; Wu X
    Adv Exp Med Biol; 2015; 871():195-212. PubMed ID: 26374220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea.
    Choi M; Han E; Lee S; Kim T; Shin W
    Adv Exp Med Biol; 2015; 871():163-79. PubMed ID: 26374218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Cell and Gene Therapy Medicinal Products in Taiwan.
    Lin YC; Wang PY; Tsai SC; Lin CL; Tai HY; Lo CF; Wu SI; Chiang YM; Liu LL
    Adv Exp Med Biol; 2015; 871():181-94. PubMed ID: 26374219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Clinical Trials with Advanced Therapy Medicinal Products in Germany.
    Renner M; Anliker B; Sanzenbacher R; Schuele S
    Adv Exp Med Biol; 2015; 871():87-101. PubMed ID: 26374214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations in the application of cell and gene therapies in children.
    Pepper MS; Pope A; Kling S; Alessandrini M; Van Staden W; Green RJ
    S Afr Med J; 2018 Nov; 108(12):1027-1029. PubMed ID: 30606284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The National Institutes of Health Oversight of Human Gene Transfer Research: Enhancing Science and Safety.
    O'Reilly M; Jambou R; Rosenthal E; Montgomery M; Hassani M; Gargiulo L; Corrigan-Curay J
    Adv Exp Med Biol; 2015; 871():31-47. PubMed ID: 26374211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
    Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
    Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The path to successful commercialization of cell and gene therapies: empowering patient advocates.
    Bauer G; Abou-El-Enein M; Kent A; Poole B; Forte M
    Cytotherapy; 2017 Feb; 19(2):293-298. PubMed ID: 27956199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical considerations in tissue engineering research: Case studies in translation.
    Baker HB; McQuilling JP; King NM
    Methods; 2016 Apr; 99():135-44. PubMed ID: 26282436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Regulatory Pathway for Advanced Cell Therapy and Gene Therapy Products in Brazil: A Road to Be Built.
    de Freitas DR
    Adv Exp Med Biol; 2015; 871():213-9. PubMed ID: 26374221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, Legal and Regulatory Issues of Paediatric Translational Research. Call for an Adequate Model of Governance.
    Altavilla A; Giannuzzi V; Lupo M; Bonifazi D; Ceci A
    Eur J Health Law; 2020 May; 27(3):213-231. PubMed ID: 33652400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive resource on EU regulatory information for investigators in gene therapy clinical research and advanced therapy medicinal products.
    Cohen-Haguenauer O
    Hum Gene Ther; 2013 Jan; 24(1):12-8. PubMed ID: 23339285
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regulatory framework of innovative therapies : From bench to bedside].
    Walter C; Rohde B; Wicke DC; Pohler C; Lührmann A; von der Leyen H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):803-10. PubMed ID: 21698532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updating the ethical guidance for gene and cell therapy research participation.
    Cargill SS; Eidsvik A; Lamm M
    Mol Ther; 2021 Aug; 29(8):2394-2395. PubMed ID: 34297921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.